Duke University Medical Center Duke University Med Ctr — Durham, North Carolina

Duke University Medical Center Duke University Med Ctr is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Duke University Medical Center Duke University Med Ctr has participated in 3 clinical trials.

Therapeutic areas: CML, Gastrointestinal Stromal Tumor (GIST), Chronic Myelogenous Leukemia in Chronic Phase.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Durham

Browse all research sites in North Carolina · View every site in Durham

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Medical Center Duke University Med Ctr?

Duke University Medical Center Duke University Med Ctr has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Medical Center Duke University Med Ctr conducted?

Duke University Medical Center Duke University Med Ctr has 3 clinical trials on record. Their work covers CML, Gastrointestinal Stromal Tumor (GIST), Chronic Myelogenous Leukemia in Chronic Phase.

Is Duke University Medical Center Duke University Med Ctr accredited by Crixeo Clinical Trials?

Duke University Medical Center Duke University Med Ctr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke University Medical Center Duke University Med Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.